21M, Still Losing Hair Fast Despite Dutasteride, Once-Daily Minoxidil & GFC Need Advice on What to Try Next Treatment 7/20/2025
A 21-year-old is experiencing aggressive hair loss despite using minoxidil, dutasteride, and GFC, and is seeking advice on whether to switch treatments or consider a hair transplant. Suggestions include continuing current treatments, checking for underlying health issues, and considering alternatives like RU58841 or microneedling.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 25M | 10 years of gradual hair loss | Minoxidil user | Looking for input on treatment optimization before HT
A 25-year-old male with 10 years of hair loss is using minoxidil and considering adding finasteride or dutasteride, possibly with microneedling, to improve hair regrowth before a hair transplant. Community members suggest starting a DHT blocker immediately, considering oral minoxidil, and addressing low vitamin D and HDL levels.
community 2026 Official Beginner’s Guide for “I’m losing my hair, what can I do?”
For hair loss, start with Finasteride, Minoxidil, Ketoconazole shampoo, and Microneedling. For severe cases, consider Dutasteride, oral Minoxidil, or hair transplants.
community 1 Year of Finasteride. 6 Months of Oral Minoxidil. Zero Results
A 25-year-old saw no improvement in hair loss after using finasteride for a year and oral minoxidil for six months. Alternatives like dutasteride, microneedling, and topical treatments were suggested, but results vary.
community My personal experience/observations fighting AGA seriously for 5 years
Minoxidil with alcohol and propylene glycol was more effective than non-alcohol versions, and RU58841 worked best in a non-water-based solution. Oral finasteride showed better results than topical, despite side effects; microneedling and tretinoin worsened hair loss, and PRP was only helpful when younger.
community 24M planning a hair transplant, having second thoughts
A 24-year-old is considering a hair transplant but is hesitant due to cost and finding his shaved head looks better than expected. He plans to try finasteride to improve hair density after unsuccessful attempts with minoxidil and dutasteride.
Related Research
6 / 6 resultsresearch Guidelines based management of androgenetic alopecia
This review examines the effectiveness of current treatments for androgenetic alopecia, offering plastic surgeons evidence-based guidance for choosing safe and effective options, but reports no new results.
research Therapeutic effects of growth factor cocktail (CellcurinTM) containing FGF5s (fibroblast growth factor 5 short) and NMN (nicotinamide mononucleotide) in patients with androgenetic alopecia: A split study
This study investigated the effects of GFC with FGF5s and NMN at a depth of 0.8 mm using a microneedle for treating hair loss, but the abstract provides no measurable results.
research Recent Advances in the Role of Fibroblast Growth Factors in Hair Follicle Growth
This review explores the role of FGF signaling in hair follicle development and highlights its potential as a new therapeutic target for hair loss, which could surpass existing treatments in terms of efficacy and safety.
research Effect of iontophoresis with growth factor cocktail containing fibroblast growth factor 5-short applied to the scalp in patients with androgenetic alopecia – A split study
This study found that iontophoresis with growth factor cocktail including fibroblast growth factor 5-short significantly increased hair density in patients with androgenetic alopecia over 24 weeks.
research Therapeutic-effects-of-growth-factor-cocktail-including-fibroblast-growth-factor-9-in-patients-with-androgenetic-alopecia-a-split-study
A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.
research Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
This study suggests that the emulsion extract of brevilin A from Centipeda minima may stimulate hair regrowth in individuals with mild to moderate vertex balding by inhibiting JAK3.